Filtered By:
Drug: Methylprednisolone

This page shows you your search results in order of date. This is page number 13.

Order by Relevance | Date

Total 691 results found since Jan 2013.

COVID-19 and corticosteroids: a narrative review
In conclusion, corticosteroid therapy is an effective way in the management of COVID-19, it reduces the risk of complications primarily acute lung injury and the development of ARDS. Besides, corticosteroid therapy mainly dexamethas one and methylprednisolone are effective in reducing the severity of COVID-19 and associated comorbidities such as chronic obstructive pulmonary diseases (COPD), rheumatoid arthritis, and inflammatory bowel disease (IBD).
Source: Inflammopharmacology - May 13, 2022 Category: Drugs & Pharmacology Source Type: research

Post ‐infectious cerebellar ataxia following COVID‐19 in a patient with epilepsy
ConclusionPost-infectious cerebellar ataxia is an unusual presentation after COVID-19. The clinician should be aware of such complications following COVID-19 infection as early diagnosis and proper management leads to better outcomes in many patients.
Source: Clinical and Experimental Neuroimmunology - May 2, 2022 Category: Neurology Authors: Sidhartha Chattopadhyay, Judhajit Sengupta, Sagar Basu Tags: CASE REPORT Source Type: research

Successful Treatment of COVID-19-Related Immune- Complex Glomerulonephritis, Case Report
Iran J Kidney Dis. 2022 Mar;16(2):147-151.ABSTRACTAcute kidney injury (AKI) , proteinuria in the nephrotic or subnephrotic range and hematuria might be seen in patients with coronavirus disease 2019 (COVID-19) infection. In this case study we present a 59 years old manwho was diagnosed with immune-complex glomerulonephritis after development of rapidly progressive kidney failure accompanied by pulmonary hemorrhage, 2 months after COVID-19 infection. The patient was hospitalised with the diagnosis of acute kidney injury and nephrotic syndrome. Hemodialysis was performed due to uremic symptoms. Cyclophosphamide, methylpredni...
Source: Iranian Journal of Kidney Diseases - April 30, 2022 Category: Urology & Nephrology Authors: Ramazan Danis Emrah Gunay Enver Yuksel Seyhmus Kaya Jehat K ılıc Emrah Kacar Ayhan Senol Derya Deniz Alt ıntas Mehmet Serdar Y ıldırım Source Type: research